1. 1) Farr RS, Cox CP, Wardlow ML, Jorgensen R: Preliminary studies of an acid-labile factor (ALF) in human sera that inactivates platelet-activating factor (PAF). Clin Immunol Immunopathol, 1980; 15: 318-330
2. 2) Tjoelker LW, Wilder C, Eberhardt C, Stafforini DM, Dietsch G, Schimpf B, Hooper S, Le Trong H, Cousens LS, Zimmerman GA, Yamada Y, McIntyre TM, Prescott SM, Gray PW: Anti-inflammatory properties of a plateletactivating factor acetylhydrolase. Nature, 1995; 374: 549-553
3. 3) Blank ML, Lee T, Fitzgerald V, Snyder F: A specific acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid). J Biol Chem, 1981; 256: 175-178
4. 4) Venable ME, Zimmerman GA, McIntyre TM, Prescott SM: Platelet-activating factor: a phospholipid autacoid with diverse actions. J Lipid Res, 1993; 34: 691-702
5. 5) Elstad MR, Stafforini DM, McIntyre TM, Prescott SM, Zimmerman GA: Platelet-activating factor acetylhydrolase increases during macrophage differentiation. A novel mechanism that regulates accumulation of platelet-activating factor. J Biol Chem, 1989; 264: 8467-8470